Cemiplimab
Product Specifications
CAS Number
1801342-60-8
Target
PD-1/PD-L1|||Others
Related Pathways
Immunology/Inflammation|||Others|||Apoptosis|||Cell Cycle/Checkpoint
Purity
>97.2%
Bioactivity
Cemiplimab (Anti-Human PD-1) is a human monoclonal antibody that inhibits the PD-1/PD-L1 pathway, serving as a checkpoint inhibitor. It is applicable in research on metastatic cancer and squamous cell skin cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
